Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,228 Cr
down ₹36.7 Cr vs Nov 2022
- Stocks held
- 24
- unchanged
- Top 10 weight
- 63.6%
- of the portfolio in its ten largest
- Cash & debt
- 4.2%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 7, trimmed 16
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In December 2022 it disclosed 24 stocks worth ₹1,228 Cr, down ₹36.7 Cr from Nov 2022. Its largest positions were Sun Pharmaceutical Industries Limited (16.2%), Cipla Limited (9.1%), Apollo Hospitals Enterprise Limited (6.8%); the ten largest together made up 63.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.9% of its equity. Cash and debt stood at 4.2%. Compared with Nov 2022 the fund entered 1 new stock and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
62%
Holds more cash than 62% of peers
What these mean: concentration · cash
Holdings in December 2022
Download CSVEvery line the fund disclosed, with the change against Nov 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 16.25% | down 0.23 pts | ₹200 Cr | down ₹8.9 Cr | Trimmed |
| Cipla Limited | 9.08% | down 0.26 pts | ₹111 Cr | down ₹6.6 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 6.79% | down 0.17 pts | ₹83.4 Cr | down ₹4.6 Cr | Trimmed |
| IPCA Laboratories Limited | 5.42% | up <0.01 pts | ₹66.6 Cr | down ₹2 Cr | Trimmed |
| Lupin Limited | 5.35% | down 0.07 pts | ₹65.7 Cr | down ₹2.9 Cr | Trimmed |
| Procter & Gamble Health Limited | 5.11% | down 0.12 pts | ₹62.7 Cr | down ₹3.3 Cr | Trimmed |
| Alkem Laboratories Limited | 4.35% | down 0.04 pts | ₹53.5 Cr | down ₹2.1 Cr | Trimmed |
| Cash, TREPS & receivables | 4.21% | up 3.29 pts | ₹51.7 Cr | up ₹40 Cr | Added |
| Dr. Reddy's Laboratories Limited | 3.86% | down 1.10 pts | ₹47.5 Cr | down ₹15.4 Cr | Trimmed |
| Indoco Remedies Limited | 3.72% | up 0.19 pts | ₹45.7 Cr | up ₹1 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.63% | down 0.32 pts | ₹44.5 Cr | down ₹5.3 Cr | Trimmed |
| Intuitive Surgical Inc | 3.36% | up 0.19 pts | ₹41.2 Cr | up ₹1.1 Cr | Added |
| Globus Medical Inc | 3.35% | up 0.26 pts | ₹41.2 Cr | up ₹2.1 Cr | Added |
| Alembic Pharmaceuticals Limited | 3.00% | down 0.02 pts | ₹36.8 Cr | down ₹1.4 Cr | Trimmed |
| Max Healthcare Institute Limited | 2.89% | down 0.99 pts | ₹35.5 Cr | down ₹13.6 Cr | Trimmed |
| Aarti Drugs Limited | 2.68% | up 0.12 pts | ₹32.9 Cr | up ₹51 L | Added |
| ICICI Lombard General Insurance Company Limited | 2.43% | up 0.12 pts | ₹29.9 Cr | up ₹62 L | Added |
| Suven Pharmaceuticals Limited | 2.40% | up 0.21 pts | ₹29.5 Cr | up ₹1.8 Cr | Added |
| Abbott Laboratories | 2.34% | up 0.23 pts | ₹28.7 Cr | up ₹2 Cr | Added |
| Zydus Lifesciences Limited | 2.06% | up 2.06 pts | ₹25.3 Cr | up ₹25.3 Cr | New |
| Syngene International Limited | 1.79% | down 0.01 pts | ₹22 Cr | down ₹83 L | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.70% | up 0.03 pts | ₹20.8 Cr | down ₹22 L | Trimmed |
| Kovai Medical Center and Hospital Limited | 1.58% | down 0.04 pts | ₹19.4 Cr | down ₹1.1 Cr | Trimmed |
| Illumina Inc | 1.14% | up 0.04 pts | ₹14.1 Cr | up ₹2 L | Held |
| MedPlus Health Services Limited | 0.96% | down 0.08 pts | ₹11.8 Cr | down ₹1.4 Cr | Trimmed |
| Pfizer Limited | 0.55% | down <0.01 pts | ₹6.8 Cr | down ₹26 L | Trimmed |
What changed, Nov 2022 to Dec 2022
New New positions (1)
- Zydus Lifesciences Limited2.1% · ₹25.3 Cr
Exited Exited (1)
- Abiomed Incwas 3.3% · ₹41.3 Cr
Added Biggest additions
- Globus Medical Incup ₹2.1 Cr (+0.26% pts)
- Abbott Laboratoriesup ₹2 Cr (+0.23% pts)
- Suven Pharmaceuticals Limitedup ₹1.8 Cr (+0.21% pts)
- Intuitive Surgical Inc
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2022, the weight rose most in Pharmaceuticals & Biotechnology (+2.7 pts) and Healthcare Equipment & Supplies (+0.7 pts), and fell most in Healthcare Services (−4.2 pts).
- Pharmaceuticals & Biotechnology61.2% → 63.9%+2.7 pts
- Healthcare Equipment & Supplies6.4% → 7.1%+0.7 pts
- Pharmaceuticals5.8% → 6.4%+0.6 pts
- Insurance2.4% → 2.6%+0.2 pts
- Healthcare Services23.2% → 18.9%−4.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2019 | Dec 2021 | Jun 2022 | Sep 2022 | Nov 2022 | Dec 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 67.9% | 52.7% | 57.1% | 59.2% | 61.2% | 63.9% |
| Healthcare Services | 19.1% | 29.8% | 26.0% | 25.1% | 23.2% | 18.9% |
| Healthcare Equipment & Supplies | — | 6.3% | 5.4% | 5.6% | 6.4% | 7.1% |
| Pharmaceuticals | 11.3% | 7.3% | 7.6% | 6.7% | 5.8% | 6.4% |
| Insurance | 1.6% | 2.4% | 2.5% | 2.4% | 2.4% | 2.6% |
| Retailing | — | 1.4% | 1.3% | 1.0% | 1.1% | 1.0% |
Allocation in Dec 2022change vs Nov 2022
- Pharmaceuticals & Biotechnology (12)63.9%▲ 2.7 pts
- Healthcare Services (6)18.9%▼ 4.2 pts
- Healthcare Equipment & Supplies (2)7.1%▲ 0.7 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Dec 2022
4.2%
▲ 3.3 pts vs Nov 2022
- Cash alone
- 4.2%
- cash and net receivables
- A year earlier
- 3.7%
- Dec 2021 · now ▲ 0.5 pts
- Last 12 months
- −0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.